Megan Larson
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 4
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Sylvain Lesné (4 shared papers)David A. Bennett (2 shared papers)Fatou Amar (2 shared papers)Mathew A. Sherman (2 shared papers)Martin Ramsden (1 shared paper)Colleen L. Forster (1 shared paper)Adriano Aguzzi (1 shared paper)Rakez Kayed (1 shared paper)
- Journals
- Journal of Neurochemistry (1 paper)Proceedings of the National Academy of Sciences (1 paper)The Journal of Immunology (1 paper)Journal of Neuroscience (1 paper)Molecular Neurodegeneration (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Megan Larson
5 papers receiving 403 citations
Peers
Comparison fields: 5 of 63
- Physiology 312
- Biological Psychiatry 22
- Neurology 59
- Cellular and Molecular Neuroscience 83
- Pharmacology 64
Countries citing papers authored by Megan Larson
This map shows the geographic impact of Megan Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Larson more than expected).
Fields of papers citing papers by Megan Larson
This network shows the impact of papers produced by Megan Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Larson. The network helps show where Megan Larson may publish in the future.
Co-authors
The 19 scholars most cited alongside Megan Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 312 | |
| 2 | 2017 | 49 | |
| 3 | 2016 | 43 | |
| 4 | 2013 | 6 | |
| 5 | 2024 | 1 |
About Megan Larson
Megan Larson is a scholar working on Physiology, Pharmacology, Computational Theory and Mathematics, Cellular and Molecular Neuroscience and Neurology, having authored 5 papers that have together received 411 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Nuclear Receptors and Signaling (1 paper), Chemokine receptors and signaling (1 paper) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Physiology (312 citations), Biological Psychiatry (22 citations), Neurology (59 citations), Cellular and Molecular Neuroscience (83 citations) and Pharmacology (64 citations). Megan Larson has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Sylvain Lesné, David A. Bennett, Fatou Amar, Mathew A. Sherman, Martin Ramsden, Colleen L. Forster, Adriano Aguzzi, Rakez Kayed, Julie A. Schneider and Fabio Benfenati. Their work appears in journals such as Journal of Neurochemistry, Proceedings of the National Academy of Sciences, The Journal of Immunology, Journal of Neuroscience and Molecular Neurodegeneration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.